Novo Nordisk stock was quoted at $39.13 on October 27, 2026, after falling 22.6% over the preceding year. The shares were also down 19.4% since the start of 2026.
Novo Nordisk stock performance
The one-year and year-to-date declines cover different periods; neither figure represents the stock’s movement on October 27 alone. The $39.13 quotation was not identified as a closing price.
The available information does not establish what drove the share-price declines.
Trailing earnings and insider activity
Novo Nordisk had earnings per share of $4.26 for the trailing 12 months, excluding non-recurring items. That figure measures past earnings rather than a forecast of future results.
No insider transactions were reported in the preceding 12 months.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
Comments
Be respectful. No spam, impersonation or private credentials. Ordinary posts and comments appear immediately; suspicious links are held for review.
Please wait…